SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,890 | -59.4% | 27,473 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $24,341 | -42.0% | 27,473 | +3.8% | 0.00% | -66.7% |
| Q3 2022 | $42,000 | +7.7% | 26,473 | +35.9% | 0.00% | +50.0% |
| Q2 2022 | $39,000 | -13.3% | 19,473 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $45,000 | -32.8% | 19,473 | +34.5% | 0.00% | -50.0% |
| Q4 2021 | $67,000 | -39.1% | 14,473 | +0.7% | 0.00% | -33.3% |
| Q3 2021 | $110,000 | -12.7% | 14,373 | +10.6% | 0.01% | -25.0% |
| Q2 2021 | $126,000 | +16.7% | 13,000 | 0.0% | 0.01% | +60.0% |
| Q1 2021 | $108,000 | +21.3% | 13,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $89,000 | -33.6% | 13,000 | +8.3% | 0.00% | -66.7% |
| Q3 2020 | $134,000 | +436.0% | 12,000 | +200.0% | 0.01% | +500.0% |
| Q2 2020 | $25,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |